Vanguard Global Advisers’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.6M Sell
211,869
-2,452
-1% -$526K 0.02% 434
2026
Q1
$47.4M Buy
+214,321
New +$52.4M 0.03% 408

Other funds holding STE

Vanguard Global Advisers's STE Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Steris (STE) stake by 1.1% in Q2 2026, selling an estimated $526K and leaving 211,869 shares worth $44.6M. The position accounts for 0.02% of the portfolio, ranked #434.

Vanguard Global Advisers first reported a position in STE in Q1 2026 and has held it in 2 quarters since. The position peaked at $47.4M in Q1 2026. 785 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Vanguard Global Advisers held 211,869 shares of Steris worth $44.6M as of Q2 2026.
  • Vanguard Global Advisers sold 2,452 Steris shares in Q2 2026, an estimated $526K.
  • Steris made up 0.02% of Vanguard Global Advisers's portfolio in Q2 2026, its #434 holding.
  • Vanguard Global Advisers first reported a position in Steris in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Steris position peaked at $47.4M in Q1 2026.
  • 785 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.